Novo raises full-year outlook as Wegovy pill sales impress
CNBC · ENGLEWOOD CLIFFS — Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates
- CODE
- RT-E14B47
- PUBLISHER
- CNBC
- TOPIC
- Business
- PUBLISHED
- 04 November 2026 · 06:55 UTC
- FIRST SEEN
- 04 November 2026 · 07:00 UTC
- ORIGINAL
- https://www.cnbc.com/2026/11/04/novo-q3-earnings-wegovy-sales.html
- SHA-256
- fb9a7655de9a07c845e2ea210fac123142ce3cae79b80f9477ab3c0034e03044
The fingerprint is the SHA-256 of the original link, the headline and the publication time joined by “|”. Anyone can recompute it to confirm the headline and link were not changed here.
Headline and short excerpt from CNBC, taken from its public news feed. The full story and its photos belong to CNBC — read it at the original. RICHTVX NEWS is an independent aggregator and is not affiliated with CNBC. Corrections: legal@richtvx.news.
More from CNBC
What Trump losing power over Congress means for Iran, Ukraine and foreign policyRT-E81A61 · BUSINESS
Americans have said 'NO TO WAR,' Iran speaker says as Democrats take CongressRT-51B118 · BUSINESS
AI stocks fall as Texas governor result raises data center risksRT-F6EC0F · BUSINESS
